Immaculada Herrero-Fresneda
Overview
Explore the profile of Immaculada Herrero-Fresneda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bremer J, Bremer J, Konig M, Kossmehl P, Kurze I, Obereisenbuchner J, et al.
Spinal Cord Ser Cases
. 2023 Jul;
9(1):37.
PMID: 37516745
Study Design: Structured patient feedback survey evaluating real-world home care use. Objectives: To assess the long-term effectiveness, tolerability, and satisfaction with the intermittent colonic exoperistalsis (ICE) treatment device MOWOOT in...
2.
McClurg D, Booth L, Herrero-Fresneda I
Clin Transl Gastroenterol
. 2021 Jan;
11(12):e00267.
PMID: 33512794
Introduction: Chronic constipation is associated with various comorbidities and reduced quality of life. Current solutions, either pharmacological or invasive, show limited efficacy. Manual colon-specific massage is a well-established intervention to...
3.
Ripoll E, Merino A, Herrero-Fresneda I, Aran J, Goma M, Bolanos N, et al.
PLoS One
. 2013 Jun;
8(6):e65068.
PMID: 23799000
Lupus nephritis (LN) is an autoimmune disorder in which co-stimulatory signals have been involved. Here we tested a cholesterol-conjugated-anti-CD40-siRNA in dendritic cells (DC) in vitro and in a model of...
4.
Llaudo I, Cassis L, Torras J, Bestard O, Franquesa M, Cruzado J, et al.
J Pharm Pharm Sci
. 2012 Sep;
15(3):407-19.
PMID: 22974789
Purpose: P-glycoprotein (Pgp) is a member of the ABC-transporter family that transports substances across cellular membranes acting as an efflux pump extruding drugs out of the cells. Pgp plays a...
5.
Ripoll E, Nacher V, Vidal A, Herrero E, Bolanos N, Torras J, et al.
Nephrol Dial Transplant
. 2012 May;
27(8):3296-305.
PMID: 22555253
Background: In renal transplantation, cold ischaemia (CI) determines acute rejection through innate immunity among others. Acute rejection episodes are a risk factor for late allograft dysfunction and proteinuria. This implies...
6.
Franquesa M, Herrero E, Torras J, Ripoll E, Flaquer M, Goma M, et al.
Stem Cells Dev
. 2012 Apr;
21(17):3125-35.
PMID: 22494435
In solid organ transplantation, mesenchymal stem cell (MSC) therapy is strongly emerging among other cell therapies due to the positive results obtained in vitro and in vivo as an immunomodulatory...
7.
Flaquer M, Lloberas N, Franquesa M, Torras J, Vidal A, Rosa J, et al.
Life Sci
. 2010 Jul;
87(5-6):147-53.
PMID: 20600147
Aims: Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists and mammalian target of rapamycin (mTOR) inhibitors share mechanisms concerning cell growth and reduction of extracellular matrix accumulation. The purpose of this study was...
8.
Chiva-Blanch G, Gimenez-Bonafe P, Llaudo I, Torras J, Cruzado J, Petriz J, et al.
J Pharm Pharm Sci
. 2010 Jan;
12(3):357-66.
PMID: 20067710
P-glycoprotein (Pgp), a protein codified by Multi Drug Resistance (MDR1) gene, has a detoxifying function and might influence the toxicity and pharmacokinetics and pharmacodynamics of drugs. Sampling strategies to improve...
9.
Torras J, Herrero-Fresneda I, Gulias O, Flaquer M, Vidal A, Cruzado J, et al.
Nephrol Dial Transplant
. 2009 Aug;
24(12):3632-40.
PMID: 19671594
Background: In clinical renal transplantation, an increase in proteinuria after conversion from calcineurin inhibitors to rapamycin has been reported. In contrast, there are studies showing a nephro-protective effect of rapamycin...
10.
Nacher V, Carretero A, Navarro M, Ayuso E, Ramos D, Luppo M, et al.
Cells Tissues Organs
. 2009 Jul;
191(2):84-95.
PMID: 19641291
Loss of renal function during normal aging is associated with vascular alterations. Consequently, new therapeutic approaches, including gene therapy, to protect renal endothelial cells are expected to be greatly beneficial....